+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report by Biomarker Type (Predictive, Safety), Therapeutic Area (Oncology, Neurology), Phase, End Use, and Region with Growth Forecasts, 2025-2030- Product Image
Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report by Biomarker Type (Predictive, Safety), Therapeutic Area (Oncology, Neurology), Phase, End Use, and Region with Growth Forecasts, 2025-2030- Product Image
New

Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report by Biomarker Type (Predictive, Safety), Therapeutic Area (Oncology, Neurology), Phase, End Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 5899620
Description Jump to:
The Biomarker Discovery Outsourcing Services Market was valued at USD 14.53 billion in 2024, and is projected to reach USD 41.27 billion by 2030, rising at a CAGR of 19.40%. The expansion of outsourced biomarker research, attributed to the increased utilization of biomarkers in clinical trials and the accelerating level of outsourcing undertaken by pharmaceutical firms are key growth factors for this market.

Furthermore, increasing adoption of liquid biopsies is expected to drive the market growth. Liquid biopsies, which involve the analysis of biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid, offer several advantages over traditional tissue biopsies, such as being less invasive and providing real-time information. As a result, the adoption of liquid biopsies has been growing rapidly, and this trend directly impacts the demand for biomarker discovery outsourcing services.

Advancements in omics technologies are expected to drive market growth in the coming years. Progress in genomics, proteomics, metabolomics, and other omics technologies has enabled the identification of novel biomarkers.Integrating data from many omics disciplines can often be advantageous for biomarker identification. This all-encompassing approach enables a more thorough comprehension of complex disorders and can result in identifying reliable, multidimensional biomarkers.Outsourcing services specializing in multi-omics data integration offer valuable expertise in this area.

An increase in drug development and clinical trials is a major contributing factor to the market growth. Biomarkers play a crucial role in drug development, helping pharmaceutical companies identify suitable drug targets, streamline clinical trial processes, and select patient populations for trials.As of 2023, the global clinical trial landscape boasts 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This reflects a notable surge compared to the roughly 365,000 registered trials documented in early 2021, underscoring the robust and ongoing growth within the field of clinical research.

Biomarker Discovery Outsourcing Services Market Report Highlights

  • Based on biomarker type, the surrogate endpoints segment accounted for the largest revenue share of 54.88% in 2024.
  • Based on therapeutic areas, the market includes oncology, neurology, cardiology, autoimmune diseases, and others.
  • Based on the discovery phase, in 2024, the biomarker identification segment accounted for the largest revenue share in the market.
  • Based on end use, the market is segmented into pharmaceutical companies, biotechnology companies, and others.
  • The biomarker discovery outsourcing services industry in North America accounted for the largest market share of 43.96% in 2024.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Biomarker Discovery Outsourcing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Demand for Biomarkers in Drug Development
3.2.1.2. Expanding R&D Investment in Biopharmaceuticals
3.2.1.3. Rising Prevalence of Chronic and Infectious Diseases
3.2.1.4. Increasing focus on personalized medicine and targeted therapies
3.2.1.5. Advancements in Omics Technologies
3.2.1.6. Increasing Role of CROs and CDMOs Owing to Cost and Time Efficiency
3.2.2. Market Restraint Analysis
3.2.2.1. Limited Reproducibility & Validation Challenges
3.2.2.2. High Cost of Biomarker Discovery & Validation
3.2.2.3. Data Privacy & Security Concerns
3.3. Technology Landscape
3.3.1. Integration of AI and Big Data in Biomarker Research
3.3.2. Omics Technologies
3.3.3. Role of Bioinformatics & Cloud Computing
3.4. Pricing Model Analysis
3.5. Value Chain Analysis
3.6. Market Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Biomarker Discovery Outsourcing Services Market: Biomarker Type Estimates & Trend Analysis
4.1. Biomarker Discovery Outsourcing Services Market, by Biomarker Type: Segment Dashboard
4.2. Biomarker Discovery Outsourcing Services Market, by Biomarker Type: Movement Analysis
4.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, by Biomarker Type, 2018-2030 (USD Million)
4.4. Predictive Biomarkers
4.4.1. Predictive Biomarkers Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Prognostic Biomarkers
4.5.1. Prognostic Biomarkers Market Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Safety Biomarkers
4.6.1. Safety Biomarkers Market Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Surrogate Endpoints
4.7.1. Surrogate Endpoints Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Biomarker Discovery Outsourcing Services Market: Therapeutic Area Estimates & Trend Analysis
5.1. Biomarker Discovery Outsourcing Services Market, by Therapeutic Area: Segment Dashboard
5.2. Biomarker Discovery Outsourcing Services Market, by Therapeutic Area: Movement Analysis
5.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, by Therapeutic Area, 2018-2030 (USD Million)
5.4. Oncology
5.4.1. Oncology Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Neurology
5.5.1. Neurology Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Cardiology
5.6.1. Cardiology Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Autoimmune Diseases
5.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
5.8. Other Therapeutic Area
5.8.1. Other Therapeutic Area Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Biomarker Discovery Outsourcing Services Market: Discovery Phase Estimates & Trend Analysis
6.1. Biomarker Discovery Outsourcing Services Market, by Discovery Phase: Segment Dashboard
6.2. Biomarker Discovery Outsourcing Services Market, by Discovery Phase: Movement Analysis
6.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, by Discovery Phase, 2018-2030 (USD Million)
6.4. Biomarker Identification
6.4.1. Biomarker Identification Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Biomarker Validation
6.5.1. Biomarker Validation Market Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Biomarker Profiling
6.6.1. Biomarker Profiling Market Estimates and Forecasts, 2018-2030 (USD Million)
6.7. Biomarker Panel Development
6.7.1. Biomarker Panel Development Market Estimates and Forecasts, 2018-2030 (USD Million)
6.8. Biomarker Selection
6.8.1. Biomarker Selection Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Biomarker Discovery Outsourcing Services Market: End Use Estimates & Trend Analysis
7.1. Biomarker Discovery Outsourcing Services Market, by End Use: Segment Dashboard
7.2. Biomarker Discovery Outsourcing Services Market, by End Use: Movement Analysis
7.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, by End Use, 2018-2030 (USD Million)
7.4. Pharmaceutical Companies
7.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Biotechnology Companies
7.5.1. Biotechnology Companies Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Biomarker Discovery Outsourcing Services Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. North America Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Europe
8.5.1. Europe Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.7. Sweden
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Competitive Scenario
8.5.9.3. Regulatory Framework
8.5.9.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Thailand
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.7. Australia
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8. MEA
8.8.1. MEA Market Estimates and Forecasts, 2018-2030 (Revenue, USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competitive Scenario
8.8.4.3. Regulatory Framework
8.8.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competitive Scenario
8.8.5.3. Regulatory Framework
8.8.5.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Company Market Share/Assessment Analysis, 2024
9.3. Company Profiles
9.3.1. Laboratory Corporation of America Holdings
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Charles River Laboratories
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Eurofins Scientific
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Celerion
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. ICON plc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Parexel International (MA) Corporation
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Proteome Sciences
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. GHO Capital
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Thermo Fisher Scientific Inc.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Evotec
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table. 1 List of Secondary Sources
Table. 2 List of Abbreviations
Table. 3 Global Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 4 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 5 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 6 Global Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 7 Global Biomarker Discovery Outsourcing Services Market, by Region, 2018-2030 (USD Million)
Table. 8 North America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
Table. 9 North America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 10 North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 11 North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 12 North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 13 U.S. Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 14 U.S. Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 15 U.S. Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 16 U.S. Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 17 Canada Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 18 Canada Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 19 Canada Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 20 Canada Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 21 Mexico Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 22 Mexico Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 23 Mexico Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 24 Mexico Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 25 Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
Table. 26 Europe Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 27 Europe Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 28 Europe Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 29 Europe Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 30 Germany Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 31 Germany Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 32 Germany Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 33 Germany Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 34 UK Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 35 UK Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 36 UK Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 37 UK Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 38 France Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 39 France Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 40 France Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 41 France Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 42 Italy Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 43 Italy Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 44 Italy Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 45 Italy Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 46 Spain Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 47 Spain Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 48 Spain Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 49 Spain Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 50 Denmark Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 51 Denmark Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 52 Denmark Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 53 Denmark Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 54 Sweden Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 55 Sweden Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 56 Sweden Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 57 Sweden Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 58 Norway Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 59 Norway Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 60 Norway Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 61 Norway Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 62 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
Table. 63 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 64 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 65 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 66 Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 67 China Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 68 China Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 69 China Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 70 China Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 71 Japan Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 72 Japan Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 73 Japan Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 74 Japan Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 75 India Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 76 India Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 77 India Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 78 India Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 79 South Korea Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 80 South Korea Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 81 South Korea Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 82 South Korea Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 83 Australia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 84 Australia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 85 Australia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 86 Australia Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 87 Thailand Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 88 Thailand Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 89 Thailand Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 90 Thailand Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 91 Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
Table. 92 Latin America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 93 Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 94 Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 95 Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 96 Brazil Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 97 Brazil Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 98 Brazil Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 99 Brazil Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 100 Argentina Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 101 Argentina Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 102 Argentina Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 103 Argentina Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 104 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018-2030 (USD Million)
Table. 105 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 106 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 107 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 108 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 109 South Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 110 South Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 111 South Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 112 South Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 113 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 114 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 115 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 116 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 117 UAE Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 118 UAE Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 119 UAE Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 120 UAE Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
Table. 121 Kuwait Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018-2030 (USD Million)
Table. 122 Kuwait Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018-2030 (USD Million)
Table. 123 Kuwait Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018-2030 (USD Million)
Table. 124 Kuwait Biomarker Discovery Outsourcing Services Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Biomarker Discovery Outsourcing Services, Market Segmentation
Figure 7 Market Driver Relevance Analysis (Current & Future Impact)
Figure 8 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 9 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Regional Marketplace: Key Takeaways
Figure 12 Global Biomarker Discovery Outsourcing Services, for Predictive Biomarkers, 2018-2030 (USD Million)
Figure 13 Global Biomarker Discovery Outsourcing Services, for Prognostic Biomarkers, 2018-2030 (USD Million)
Figure 14 Global Biomarker Discovery Outsourcing Services, for Safety Biomarkers, 2018-2030 (USD Million)
Figure 15 Global Biomarker Discovery Outsourcing Services, for Surrogate Endpoints, 2018-2030 (USD Million)
Figure 16 Global Biomarker Discovery Outsourcing Services, for Oncology, 2018-2030 (USD Million)
Figure 17 Global Biomarker Discovery Outsourcing Services, for Neurology, 2018-2030 (USD Million)
Figure 18 Global Biomarker Discovery Outsourcing Services, for Cardiology, 2018-2030 (USD Million)
Figure 19 Global Biomarker Discovery Outsourcing Services, for Autoimmune Diseases, 2018-2030 (USD Million)
Figure 20 Global Biomarker Discovery Outsourcing Services, for Other Therapeutic Area, 2018-2030 (USD Million)
Figure 21 Global Biomarker Discovery Outsourcing Services, for Biomarker Identification, 2018-2030 (USD Million)
Figure 22 Global Biomarker Discovery Outsourcing Services, for Biomarker Validation, 2018-2030 (USD Million)
Figure 23 Global Biomarker Discovery Outsourcing Services, for Biomarker Profiling, 2018-2030 (USD Million)
Figure 24 Global Biomarker Discovery Outsourcing Services, for Biomarker Panel Development, 2018-2030 (USD Million)
Figure 25 Global Biomarker Discovery Outsourcing Services, for Biomarker Selection, 2018-2030 (USD Million)
Figure 26 Global Biomarker Discovery Outsourcing Services, for Pharmaceutical Companies, 2018-2030 (USD Million)
Figure 27 Global Biomarker Discovery Outsourcing Services, for Biotechnology Companies, 2018-2030 (USD Million)
Figure 28 Global Biomarker Discovery Outsourcing Services, for Other End Use, 2018-2030 (USD Million)
Figure 29 Regional Outlook, 2024 & 2030
Figure 30 North America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 U.S. Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Canada Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Mexico Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Europe Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 UK Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Germany Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 France Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Italy Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Spain Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Denmark Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Sweden Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Norway Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Asia Pacific Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 India Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 China Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Japan Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 South Korea Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 48 Australia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Thailand Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Latin America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Brazil Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Argentina Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 MEA Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 South Africa Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Saudi Arabia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 UAE Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Kuwait Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018-2030 (USD Million)

Companies Mentioned

The major companies profiled in this Biomarker Discovery Outsourcing Services market report include:
  • LabCorp
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Celerion
  • ICON plc
  • Parexel International (MA) Corporation
  • Proteome Sciences
  • GHO Capital
  • Thermo Fisher Scientific Inc.
  • Evotec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 14.53 Billion
Forecasted Market Value ( USD ) by 2030 $ 41.27 Billion
Compound Annual Growth Rate19.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biomarker Discovery Outsourcing Services Global Market Report 2024 - Product Image

Biomarker Discovery Outsourcing Services Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Biomarker Discovery Outsourcing Service Market by Type, by Therapeutic Area, by Discovery Phase, by End-user, and by Region - Product Image

Biomarker Discovery Outsourcing Service Market by Type, by Therapeutic Area, by Discovery Phase, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Biomarkers: Discovery Techniques and Applications - A Global Market Overview - Product Image

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

  • Report
  • 316 Pages
  • Global
From
Biomarker Clinical Phase Outsourcing Services Global Market Report 2024 - Product Image

Biomarker Clinical Phase Outsourcing Services Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Biomarker Testing Services Market Size, Share & Trends Analysis Report By Service (Biomarker Assay Development & Validation, Flow Cytometry), By Application (Oncology, Drug Discovery & Development), By Type, By End-use,By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biomarker Testing Services Market Size, Share & Trends Analysis Report By Service (Biomarker Assay Development & Validation, Flow Cytometry), By Application (Oncology, Drug Discovery & Development), By Type, By End-use,By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.